Literature DB >> 7534044

Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis.

M C van Bruggen1, K Kramers, M N Hylkema, J van den Born, M A Bakker, K J Assmann, R J Smeenk, J H Berden.   

Abstract

Recently we found in biopsies of human lupus nephritis a nearly complete loss of heparan sulfate (HS) staining in the glomerular basement membrane (GMB). To clarify the relationship between HS staining and albuminuria in lupus nephritis, we studied MRL/lpr mice with short (< 7 days) or prolonged duration of albuminuria (14-21 days) and compared these with mice of different ages without albuminuria. Kidney sections were stained for mouse immunoglobulin (Ig), HS, heparan sulfate proteoglycan (HSPG)-core protein and laminin in immunofluorescence. In mice with prolonged albuminuria HS staining in the glomerular capillary loops had almost completely disappeared, whereas staining was unaltered in non-albuminuric mice (P = 0.001). In mice with short duration of albuminuria, there was a tendency toward a decrease of HS staining (P = 0.06). The expression of HSPG-core protein and other extra cellular matrix (ECM) components was unaltered in all groups. HS staining correlated inversely with albuminuria (rs = -0.55; P < 0.001) and with staining of Ig deposits in the capillary loops (rs = -0.74; P < 0.001). Despite the nearly complete loss of HS staining in the GBM in mice with prolonged albuminuria, there was no change in glomerular HS content as assessed by agarose electrophoresis and HS inhibition ELISA. We conclude that the development of albuminuria in MRL/lpr mice is accompanied by a loss of HS staining in the GBM, probably due to the masking of HS by deposits of Ig. In vitro studies revealed that autoantibodies complexed to nucleosomal antigens can inhibit the binding of the anti-HS monoclonal antibody to HS. Whether this also occurs in vivo remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534044      PMCID: PMC1869173     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels.

Authors:  C H van de Lest; E M Versteeg; J H Veerkamp; T H van Kuppevelt
Journal:  Anal Biochem       Date:  1994-09       Impact factor: 3.365

2.  Higher anti-heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations; a long term prospective analysis.

Authors:  C Kramers; R M Termaat; E J ter Borg; M C van Bruggen; C G Kallenberg; J H Berden
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

3.  Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane.

Authors:  J T Tamsma; J van den Born; J A Bruijn; K J Assmann; J J Weening; J H Berden; J Wieslander; E Schrama; J Hermans; J H Veerkamp
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

4.  Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases.

Authors:  J van den Born; L P van den Heuvel; M A Bakker; J H Veerkamp; K J Assmann; J J Weening; J H Berden
Journal:  Kidney Int       Date:  1993-02       Impact factor: 10.612

5.  Detection of hidden nephritogenic antigen determinants in human renal and nonrenal basement membranes.

Authors:  K Yoshioka; A F Michael; J Velosa; A J Fish
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

6.  Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo.

Authors:  C Kramers; M N Hylkema; M C van Bruggen; R van de Lagemaat; H B Dijkman; K J Assmann; R J Smeenk; J H Berden
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

7.  Nephritogenicity of anti-proteoglycan antibodies in experimental murine lupus nephritis.

Authors:  N Kashihara; H Makino; Z Szekanecz; C R Waltenbaugh; Y S Kanwar
Journal:  Lab Invest       Date:  1992-12       Impact factor: 5.662

8.  Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues.

Authors:  J van den Born; L P van den Heuvel; M A Bakker; J H Veerkamp; K J Assmann; J H Berden
Journal:  J Histochem Cytochem       Date:  1994-01       Impact factor: 2.479

9.  A role for histones and ubiquitin in lupus nephritis?

Authors:  F Stöckl; S Muller; S Batsford; T Schmiedeke; R Waldherr; K Andrassy; Y Sugisaki; K Nakabayashi; T Nagasawa; B Rodriguez-Iturbe
Journal:  Clin Nephrol       Date:  1994-01       Impact factor: 0.975

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.

Authors:  Dorin-Bogdan Borza
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

2.  Increased excretions of glycosaminoglycans and heparan sulfate in lupus nephritis and rheumatoid arthritis.

Authors:  Ilhan Biçer; Kenan Aksu; Zuhal Parildar; Tijen Tanyalçin; Eker Doğanavşargil; Fatma Z Kutay
Journal:  Rheumatol Int       Date:  2003-03-12       Impact factor: 2.631

Review 3.  Autoantibodies in systemic lupus erythematosus.

Authors:  Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2011-12-23       Impact factor: 3.651

Review 4.  Basement Membrane Defects in Genetic Kidney Diseases.

Authors:  Christine Chew; Rachel Lennon
Journal:  Front Pediatr       Date:  2018-01-29       Impact factor: 3.418

5.  Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy.

Authors:  Wentian Luo; Florina Olaru; Jeffrey H Miner; Laurence H Beck; Johan van der Vlag; Joshua M Thurman; Dorin-Bogdan Borza
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

6.  Unchanged distribution density of anionic sites on the glomerular wall in rats with active heymann nephritis.

Authors:  Akihito Shimoi; Hirofumi Hatakeyama; Seiji Miyoshi; Mitsutoshi Watanabe
Journal:  J Toxicol Pathol       Date:  2013-04-22       Impact factor: 1.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.